The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 07, 2020
Filed:
Mar. 14, 2017
Applicant:
Zyngenia, Inc., Washington, DC (US);
Inventors:
Viktor Roschke, Bethesda, MD (US);
David Lafleur, Washington, DC (US);
David M. Hilbert, Bethesda, MD (US);
Peter Kiener, Potomac, MD (US);
Assignee:
Zygenia, Inc., Washington, DC (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/46 (2006.01); C07K 16/24 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 7/08 (2006.01); A61K 39/00 (2006.01); C07K 14/47 (2006.01); C07K 16/28 (2006.01); C07K 16/22 (2006.01); C07K 16/32 (2006.01); C07K 16/40 (2006.01); C07K 14/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 14/00 (2013.01); C07K 16/22 (2013.01); C07K 16/24 (2013.01); C07K 16/241 (2013.01); C07K 16/2803 (2013.01); C07K 16/2809 (2013.01); C07K 16/2839 (2013.01); C07K 16/2848 (2013.01); C07K 16/2863 (2013.01); C07K 16/32 (2013.01); C07K 16/40 (2013.01); C07K 16/468 (2013.01); A61K 2039/505 (2013.01); C07K 7/08 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/60 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/76 (2013.01); C07K 2317/90 (2013.01); C07K 2319/01 (2013.01); C07K 2319/30 (2013.01); C07K 2319/33 (2013.01); C07K 2319/35 (2013.01); C07K 2319/40 (2013.01); C07K 2319/70 (2013.01); C07K 2319/74 (2013.01);
Abstract
Compositions containing multivalent and monovalent multispecific complexes having scaffolds such as antibodies that support such binding functionalities are described. The use of and methods of compositions containing multivalent and monovalent multispecific complexes having scaffolds, such as antibodies, that support such binding functionalities are also described.